Psychiatry · Clackamas, OR
NPI
1083707897
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9800 SE Sunnyside Rd
Clackamas, OR, 97015
Phone (800) 813-2000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$116K
2,935 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Cheryl A Chessick prescribed most often to Medicare patients was Trazodone Hcl, with 243 prescriptions and refills. In total Cheryl A Chessick wrote 2,935 Medicare prescriptions that cost $116K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Trazodone Hcl Generic | 243 | 505 | 68 | $4,807 |
| Clonazepam Generic | 237 | 241 | 49 | $2,676 |
| Lamotrigine Generic | 129 | 354 | 44 | $3,087 |
| Quetiapine Fumarate Generic | 128 | 216 | 31 | $2,647 |
| Lorazepam Generic | 126 | 126 | 42 | $1,556 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 106 | 106 | 22 | $3,392 |
| Alprazolam Generic | 104 | 104 | 25 | $782 |
| Sertraline Hcl Generic | 98 | 208 | 29 | $1,138 |
| Duloxetine Hcl Generic | 97 | 241 | 25 | $2,175 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 93 | 233 | 27 | $2,302 |
| Buspirone Hcl Generic | 86 | 189 | 28 | $1,330 |
| Aripiprazole Generic | 76 | 194 | 20 | $1,198 |
| Zolpidem Tartrate Generic | 73 | 73 | 15 | $549 |
| Mirtazapine Generic | 72 | 145 | 25 | $1,458 |
| Olanzapine Generic | 70 | 142 | 14 | $1,171 |
Brand drugs: 58 claims; generic drugs: 2,877 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Cheryl A Chessick were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.